key: cord-0911919-r303bvc5
authors: Odeh, Mohanad M.; Al Qaissieh, Rami; Tarifi, Amjad A.; Kilani, Muna M.; Tadros, Ramzy E.; Al khashman, Abedrazzaq I.; Alzoubi, Karem H.
title: A Prediction Model of Risk Factors for Complications among SARS-CoV2 Positive Patients: Cases from Jordan
date: 2021-03-06
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2021.02.010
sha: 696f83b41342fc6a51eb507449dbc71666628dfa
doc_id: 911919
cord_uid: r303bvc5

BACKGROUND: The number of COVID-19 infected patients has been soaring in the Middle East countries. The disease poses a significant threat, decisions about prioritizing care should be made in accordance with the proven risk factors for complications. OBJECTIVE: The present study provides the first bespoke prediction model in the Middle East to identify COVID-19 patients, who are at higher risk for complications. METHOD: A case-control study design was adopted to compare the characteristics of successfully recovered patients with those who had complications. Complications were defined as admission to the intensive care unit, mechanical ventilation, sepsis or septic shock, pneumonia or respiratory failure, and death. The prediction model was created through multivariable logistic regression. C statistic was used to assess overall discriminatory ability. RESULTS: All COVID-19 infected hospitalized patients (n = 133) in Amman – Jordan were included in the study. Successfully recovered were 125 patients. The median age (IRQ) was 26 (10-40). Almost 30% were >40 years. Patients with complications were eight patients, age 63 (51.5-71.5). The prediction model identified the following variables as risk factors: diabetes (OR = 59.7; 95% CI: 3.5–1011.5, P = 0.005), fever (OR = 24.8; 95% CI: 1.4–447.3, P = 0.029), SHORTNESS OF BREATH (OR = 15.9; 95% CI: 1.3–189.7, P = 0.029), body mass index (OR = 0.74; 95% CI: 0.61–0.88, P = 0.001), abnormal Neutrophils (OR = 16.8; 95% CI: 1.0–292.0, P = 0.053). Prediction model was statistically significant, χ2(5) = 86.1, p < 0.0005. CONCLUSIONS: Unlike reports from China, the most influential variables that led to disease progression in Jordanian patients were diabetes, fever, shortness of breath, body mass index, and abnormal neutrophils. Similar to reports from the USA, smoking was not a leading factor for complications. Comorbidities and patient health status, rather than age, were the primary risk factors for complications. Treatment with Hydroxychloroquine showed no protective effect.

The majority of patients with COVID-19, the disease caused by the SARS-CoV-2 virus, were asymptomatic or showed mild symptoms of the disease 5, 6 . Approximately 20% of the infected patients were admitted to ICU, due to severity of illness and complication. Unfortunately, cases of death were reported as well 6 . In Italy, about 9% of patients who tested positive for the SARS-CoV2 virus were transferred to the ICU. Whereas in China, the ICU was needed for 5-32% of COVID-19 hospitalized patients [7] [8] [9] .

Old age, male sex, hypertension, diabetes, and cardiovascular disease were identified as risk factors associated with both ICU admission and subsequent death 5, 7,10-12 . Elevated D-Dimer and lymphopenia were also associated with worse prognosis 11 . A recent study in the US found that hospitalized patients were more likely to be obese, male, having cardiovascular disease and diabetes compared with non-hospitalized patients, an early elevation in D-Dimer and CRP were also indicators of a more complicated course 13 . During triage, it is crucial to identify J o u r n a l P r e -p r o o f COVID-19 patients who are at higher risk for complications. Not only for better resource optimization but also for delivering tailored patients' care.

The first case of COVID-19 in Jordan was reported on March 2 nd , 2020, as of April 18th, 2020 there have been 413 cases of the SARS-CoV2 virus infection and 7 cases of death 14 . In Amman, the capital city of Jordan, Prince Hamza Hospital was designated to be the main hospital for COVID-19 infected patients. Such setup offered a unique opportunity to study and identify the risk factors for COVID-19 related complications. Moreover, it enabled us to create a prediction model to identify patients at higher risk for such complications.

Ethical approvals were provided by Prince Hamza Hospital Internal Review Board (IRB) (Approval code: 2/1/1641) and the Hashemite University IRB (Approval code: 5/5/2019/2020).

The study was conducted at Prince Hamza Hospital, the main hospital to screen and manage corona infections in the capital city of Jordan, Amman. Hospitalized patients with laboratoryconfirmed coronavirus were included in the study. COVID-19 infection confirmation was based on results of real-time reverse transcriptase-polymerase-chain-reaction (RT-PCR) and the assay of nasopharyngeal (or oropharyngeal) swab specimens. Administrative, electronic health records, clinical, and laboratory data were collected for patients admitted between March 15, 2020, and April 6, 2020, with follow up through April 23 rd , 2020.

The case-control study design was adopted for the present study. Patients who had complications were considered the cases for the disease progression, while infected and recovered patients were the recovery group.

J o u r n a l P r e -p r o o f

Patients who had any of the following criteria were considered within the progressed group: admission to ICU, having received mechanical ventilation, sepsis or septic shock, pneumonia or respiratory failure, and death. The following respiratory parameters were considered also within the complication: respiratory distress, RR ≥30 breaths/min; oxygen saturation < 93% at rest; partial pressure of oxygen (PaO2)/fraction of inspired oxygen < 300 mmHg. Patients who had been discharged without complications were considered the successfully recovered group.

The following data was collected for each patient: gender and age, weight and height, body mass index (BMI) was calculated as weight / (height 2 ), smoking status. Comorbidities including hypertension, ischemic heart disease, diabetes, hyperlipidemia, hypothyroidism, gastroesophageal reflux disease (GERD), migraine, palpitations, chronic obstructive pulmonary disease (COPD), receiving hydroxychloroquine medication, were also considered. Data was collected for the following symptoms: cough (dry or wet), fever, chills and/or rigors, sweating, generalized malaise, myalgia, shortness of breath (SOB), headache, hemoptysis, diarrhea, chest pain, abdominal pain, palpitations, loss of taste, loss of smell, nasal congestion, rhinorrhea, and others like sneezing, conjunctivitis, sore throat, vomiting, gum and tooth pain, paranesthesia. Data for the following lab tests results were collected, hemoglobin (Hb), hematocrit (HTC), weight blood cells (WBC), neutrophils, lymphocytes, basophils, monocytes, eosinophils, platelets, C-reactive protein, urea, creatinine in serum, sodium, potassium, bilirubin (total), bilirubin (directconjugated), aspartate aminotransferase (AST) and alanine aminotransferase (ALT), prothrombin time (PT), international normalized ratio (INR) and D-Dimer.

Descriptive statistics were presented for all recruited patients. Data for patients older than 20 years were compared between the recovery and progress group. To carry out univariate J o u r n a l P r e -p r o o f analysis, continuous variables were analyzed using the Mann-Whitney U test. Categorical variables were analyzed using the Chi-squared test or Fisher's exact test. Freeman-Halton extension of the Fisher exact probability test was carried out for a two-rows by three-columns contingency table. The odds ratio along with the 95% Confidence Interval (CI) for each predictor was also calculated. Statically significant value for each predictor was presented. Due to sample size, only eight predictors were selected to be transferred to the multivariable regression model, Predictors that demonstrated statistically significant differences between the groups were considered for further analysis, as a risk factor for progression. With consideration to prior published literature and the clinical experience with COVID-19 patients, the top eight predictors were selected for the process of stepwise, backward regression.

For evaluating the quality of the logistic regression results (i.e., model fit), overall statistical significance tests for models were carried out. The Omnibus Test of Model Coefficients 15 was used to measure how well the final model predicted categories compared to the baseline model and other previous models in the backward stepwise approach (i.e. P-value for the final model should be <0.05). The Hosmer and Lemeshow goodness of fit test 16 was used to assess how good the model was at predicting the categorical outcomes (i.e. a good model has P>0.05 and a poorly fitting model has significant P-value). All data were managed and analyzed by using SPSS version 26.

Between March 15 th and April 6 th , 2020, A total of 133 patients were admitted to Prince Hamza hospital in Amman, Jordan, and recruited in this study. A visual summary is shown in Figure 1 , which illustrates that 125 patients have successfully recovered. Table 1 summarizes the demographic variables. The median age was 26 years (interquartile range 10-40 years), 24.2% were less than 20 years old, and 30% were over 40 years of age. There were only eight patients who had medical complications; their median age was 63 years (51.5-71.5 years).

The following factors demonstrated a statistically significant association with complications ( Table 6 , regression model demonstrates the following risk factors as statistically significant predictors for complications: An increase in one unit of the categorical variables (i.e., being diabetic, having fever, SOB and abnormal neutrophil count) will increase the odds for progression to complication as follows: diabetes ( OR = 59.7; 95% CI: 3. It was noticed that 42.4% of infected patients were younger than 20 years, this may be because Jordan has a young population where the median population age is 22 years 19 . Family relationship and social lifestyle in Jordan encourages closeness, which makes social distancing more difficult. Data show that almost all the infected patients younger than 20 years had at least one infected individual of their families in the older age categories. However, no patient at this age group has developed any complications. Accordingly, they were not included in our univariate nor multivariate analysis.

The age distribution of infected patients differed between countries. In Jordan for example, in the present study, we had only one infected patient older than 75 years, who was in the progression group, while data from USA 13 suggested that strongest hospitalization risk was age ≥75 years (OR= 66.8, 95% CI, 44.7-102.6). Data from Italy 7 showed that among 1591 patients J o u r n a l P r e -p r o o f admitted to ICU, 363 (22.8%) were older than 70 years, this percentage is significantly higher than data in Jordan. However, age ranges in Jordan may be close to those presented in china by Liu et al 12 Current results confirmed that early SOB is a strong indicator for complications, where having SOB increases the odds for complications by 15.9 (95% CI: 1.3 -189.7, P= 0.029). This supports others' work as Wu et.al 5 , who reported that patients developed acute respiratory distress syndrome have more percentage of patients with dyspnea compared to those who recovered 59.5% vs 25.6% respectively. While age is a well-defined risk factor for complications 5, 12, 13 , its impact in our analysis was attenuated by multivariable adjustment for other variables, this might be due to the comparable age scale between the two study groups in the present study.

The D-dimer was documented as a strong factor associated with progression and subsequent death in China 5,11 and the USA 13 but not Italy 7 . In Jordan, the sample size for patients who underwent the D-dimer test was very small as seen in Table 5 . Accordingly, with reference to these reasons and with the results documented by Liu et al 12 , we decided to skip D-dimer from the prediction model. Similarly, missing data for procalcitonin levels had prevented the addition of it to the prediction model in the present study.

In the current prediction model cardiac related problems, abnormal levels for C-reactive protein, and creatinine failed to demonstrate a statistically significant association with complications, unlike results shown by other researchers 12, 13 . Our data did not identify smoking as risk factor for complication, this result is not supporting Liu et al 12 

With reference to the prediction model for Jordan and the Middle East, patients identified with fever, shortness of breath, and diabetes should be closely supervised and observed. They have an increased risk for complications. Smoking was not identified as a risk factor for complications, and hydroxychloroquine treatment had no benefit.

MO contributed to study design, data analysis, and writing. RA, AT, MK, RT, and AA contributed to study design, data collection, and manuscript writing. KA participated in study design, manuscript writing.

None.

J o u r n a l P r e -p r o o f  1 1 1 1 1 1 1 1 1 1 1 Performance for patients diagnosed with SARS-CoV-2 J o u r n a l P r e -p r o o f 

A pneumonia outbreak associated with a new coronavirus of probable bat origin

<em>Severe acute respiratory syndromerelated coronavirus</em>: The species and its viruses -a statement of the Coronavirus Study Group. bioRxiv

World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19: 11

Coronavirus COVID-19 Global cases by the Cener for Systems Sciences and Engineering (CSSE) at Johns Hopkins univeristy

Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease

Coronavirus Disease 2019 (COVID-19) in Italy

Baseline Characteristics and Outcomes of 1591

Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv

Local and omnibus goodness-of-fit tests in classical measurement error models

Applied Logistic Regression

National Emergency Plan for Management of (COVID 19)

Jordan's official Covid 19 website homepage